Long-term prevention of attacks with lanadelumab across subgroups of patients with hereditary angioedema (HAE): final results from the HELP open-label extension studyM. Maurer, J. A. Bernstein,J. Jacobs,W. R. Lumry,H. Ren,D. Soteres, M. Yu, I Martinez-SaguerALLERGY(2021)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要